Found: 46
Select item for more details and to access through your institution.
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 6, p. 2158, doi. 10.1093/brain/awae034
- By:
- Publication type:
- Article
High VEGF‐A and low PlGF in plasma are associated with reduced longitudinal tau PET burden and slower cognitive decline in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082453
- By:
- Publication type:
- Article
Evaluating the biological variability of blood‐based biomarkers for use in clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.066629
- By:
- Publication type:
- Article
A multimodal pilot study of default mode network (DMN) connectivity across the lifespan in healthy volunteers using functional imaging, CSF, and plasma Alzheimer's disease biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.066591
- By:
- Publication type:
- Article
Using Proteomics Analysis to Identify Cerebrospinal Fluid Biomarkers in Normal Pressure Hydrocephalus.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.067160
- By:
- Publication type:
- Article
Applying Data‐Independent Acquisition Mass Spectrometry on Cerebrospinal Fluid Samples from a Neurology Clinic for Biomarker Discovery in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.064314
- By:
- Publication type:
- Article
Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively unimpaired older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 645, doi. 10.1002/alz.12399
- By:
- Publication type:
- Article
The technical reliability and stability of ATN quantification using the Fujirebio Lumipulse G1200 fully‐automated immunoassay instrument in cerebrospinal fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056415
- By:
- Publication type:
- Article
Levels of the synaptic proteins PSD‐95, SNAP‐25, and neurogranin are selectively increased in the cerebrospinal fluid of patients with Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056339
- By:
- Publication type:
- Article
Using cerebrospinal fluid ATN quantification to classify research subjects in a diverse clinical population.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056328
- By:
- Publication type:
- Article
Matrix metalloproteinase‐10 as a novel biomarker of neurodegeneration in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056323
- By:
- Publication type:
- Article
A comparison of multiple platforms for quantifying ATN values in cerebrospinal fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056321
- By:
- Publication type:
- Article
Technical performance and biotemporal stability evaluation of Olink proximity extension assay for blood‐based biomarker discovery.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056318
- By:
- Publication type:
- Article
Characterizing proteoforms of the granin family of neuropeptides in dementia pathophysiology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056265
- By:
- Publication type:
- Article
Characterization of novel neuropeptide proteolytic processing involved in dementia pathophysiology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058553
- By:
- Publication type:
- Article
Plasma biomarkers of neuroinflammation and vascular injury predict cognitive decline in patients with mild cognitive impairment: Biomarkers (non‐neuroimaging)/Plasma/Serum/Urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046134
- By:
- Publication type:
- Article
Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively normal older adults: Biomarkers (non‐neuroimaging)/Plasma/Serum/Urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045497
- By:
- Publication type:
- Article
Characterizing chromogranin and secretogranin proteoforms in dementia pathophysiology: Molecular and cell biology/neurodegeneration and neuroprotection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044624
- By:
- Publication type:
- Article
Development of a robust and stable mass based spectrometry method for analysis of Alzheimer's disease biomarkers in human cerebrospinal fluid: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042035
- By:
- Publication type:
- Article
P4‐217: A MULTIPLE PATHOPHYSIOLOGY PANEL FOR CLINICAL TRIALS IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1359, doi. 10.1016/j.jalz.2019.06.3880
- By:
- Publication type:
- Article
P4‐173: SUBCELLULAR ORGANELLE FRACTIONATION FOR PROTEOMIC ANALYSIS IN POSTMORTEM ALZHEIMER'S DISEASE TISSUE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1341, doi. 10.1016/j.jalz.2019.06.3835
- By:
- Publication type:
- Article
P3‐346: TASK‐RELATED FMRI ACTIVITY DURING AN INSULIN CLAMP PROCEDURE IN OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1075, doi. 10.1016/j.jalz.2019.06.3378
- By:
- Publication type:
- Article
P1‐269: DEVELOPMENT AND TECHNICAL VALIDATION OF A DATA‐INDEPENDENT ACQUISITION METHODOLOGY FOR ANALYSIS OF HUMAN ALZHEIMER'S DISEASE CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P342, doi. 10.1016/j.jalz.2019.06.824
- By:
- Publication type:
- Article
O1‐01‐05: PROTEOMIC ASSESSMENT OF SYNAPSES WITH RICH ASSOCIATED CLINICAL DATA HIGHLIGHTS POTENTIAL TARGETS FOR MEDIATING ALZHEIMER'S PATHOLOGY AND COGNITIVE DECLINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P192, doi. 10.1016/j.jalz.2019.06.4521
- By:
- Publication type:
- Article
P3‐220: ULTRA‐SENSITIVE DETECTION OF CENTRAL NERVOUS SYSTEM BIOMARKERS IN BLOOD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1155, doi. 10.1016/j.jalz.2018.06.1579
- By:
- Publication type:
- Article
P1‐274: A TARGETED MASS‐SPECTROMETRY METHOD FOR QUANTIFICATION OF CEREBROSPINAL FLUID BIOMARKERS OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P387, doi. 10.1016/j.jalz.2018.06.280
- By:
- Publication type:
- Article
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology.
- Published in:
- Brain & Behavior, 2021, v. 11, n. 4, p. 1, doi. 10.1002/brb3.2048
- By:
- Publication type:
- Article
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.889647
- By:
- Publication type:
- Article
Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70822-8
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias.
- Published in:
- Proteomes, 2018, v. 6, n. 3, p. 32, doi. 10.3390/proteomes6030032
- By:
- Publication type:
- Article
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 1, doi. 10.3389/fneur.2023.1069411
- By:
- Publication type:
- Article
Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid.
- Published in:
- Brain Pathology, 2022, v. 32, n. 2, p. 1, doi. 10.1111/bpa.13035
- By:
- Publication type:
- Article
Plasma biomarkers for prognosis of cognitive decline in patientswithmild cognitive impairment.
- Published in:
- Brain Communications, 2022, v. 4, n. 4, p. 1, doi. 10.1093/braincomms/fcac155
- By:
- Publication type:
- Article
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases.
- Published in:
- Brain Communications, 2021, v. 3, n. 4, p. 1, doi. 10.1093/braincomms/fcab261
- By:
- Publication type:
- Article
Plasma Neurofilament Light Chain Is Elevated in Adaptor Protein Complex 4‐Related Hereditary Spastic Paraplegia.
- Published in:
- Movement Disorders, 2023, v. 38, n. 9, p. 1742, doi. 10.1002/mds.29524
- By:
- Publication type:
- Article
TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X‐linked Dystonia‐Parkinsonism.
- Published in:
- Movement Disorders, 2021, v. 36, n. 1, p. 206, doi. 10.1002/mds.28305
- By:
- Publication type:
- Article
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2024, v. 10, n. 3, p. 1, doi. 10.1002/trc2.12487
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker profiling of diverse pathophysiological domains in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2024, v. 10, n. 1, p. 1, doi. 10.1002/trc2.12440
- By:
- Publication type:
- Article
Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.
- Published in:
- BMC Infectious Diseases, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12879-021-06257-7
- By:
- Publication type:
- Article
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.
- Published in:
- 2021
- By:
- Publication type:
- journal article
CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01151-z
- By:
- Publication type:
- Article
Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01002-x
- By:
- Publication type:
- Article
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193707
- By:
- Publication type:
- Article